Vitamin Shoppe (NYSE:VSI) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday, reports.

According to Zacks, “Vitamin Shoppe is a specialty retailer and direct marketer of nutritional products. It primarily sells vitamins, minerals, nutritional supplements, herbs, sports nutrition formulas, homeopathic remedies, green living products and health and beauty aids. Based in North Bergen, New Jersey, the company is recognized as an innovator in providing product information, associate training, and customer education. Information is available to consumers through unprecedented outlets including television, radio, friends, family, health practitioners, and the internet. It offers consumers the opportunity to take charge of their own health and wellness requirements, and supplement where necessary. At each store location, consumers can find a comprehensive Learning Center which offers free access to vital information about key health concerns and products. The Vitamin Shoppe is a strong supporter of health and wellness campaigns including Life Supplemented sponsored by the Council for Responsible Nutrition. “

Other research analysts have also issued reports about the stock. Jefferies Financial Group lowered their target price on shares of Huntsman from $33.00 to $30.00 and set a “buy” rating on the stock in a research report on Monday, June 17th. ValuEngine lowered shares of Zumiez from a “hold” rating to a “sell” rating in a research report on Tuesday, July 2nd. One analyst has rated the stock with a sell rating and four have given a hold rating to the company. Vitamin Shoppe has an average rating of “Hold” and a consensus price target of $7.92.

VSI traded up $0.19 on Friday, hitting $4.23. 441,749 shares of the company were exchanged, compared to its average volume of 466,037. The company has a quick ratio of 0.16, a current ratio of 1.14 and a debt-to-equity ratio of 2.36. The business has a fifty day moving average price of $3.85. Vitamin Shoppe has a fifty-two week low of $3.32 and a fifty-two week high of $13.95. The firm has a market capitalization of $96.93 million, a price-to-earnings ratio of 16.27 and a beta of 1.65.

Vitamin Shoppe (NYSE:VSI) last issued its earnings results on Wednesday, May 8th. The specialty retailer reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.24 by ($0.03). Vitamin Shoppe had a return on equity of 4.64% and a net margin of 0.33%. The company had revenue of $283.33 million for the quarter. On average, sell-side analysts predict that Vitamin Shoppe will post 0.54 earnings per share for the current fiscal year.

Institutional investors and hedge funds have recently modified their holdings of the business. RMB Capital Management LLC acquired a new position in Vitamin Shoppe during the fourth quarter worth about $483,000. Macquarie Group Ltd. grew its position in Vitamin Shoppe by 114.0% during the fourth quarter. Macquarie Group Ltd. now owns 10,136 shares of the specialty retailer’s stock worth $48,000 after buying an additional 5,400 shares during the period. Investors Research Corp purchased a new stake in shares of Vitamin Shoppe in the first quarter valued at about $34,000. Two Sigma Advisers LP lifted its holdings in shares of Vitamin Shoppe by 10.8% in the fourth quarter. Two Sigma Advisers LP now owns 180,743 shares of the specialty retailer’s stock valued at $857,000 after purchasing an additional 17,550 shares in the last quarter. Finally, FMR LLC lifted its holdings in shares of Vitamin Shoppe by 1.3% in the fourth quarter. FMR LLC now owns 1,645,611 shares of the specialty retailer’s stock valued at $7,800,000 after purchasing an additional 20,848 shares in the last quarter. Institutional investors own 88.97% of the company’s stock.

About Vitamin Shoppe

Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.

Further Reading: What can cause a stock to outperform?

Get a free copy of the Zacks research report on Vitamin Shoppe (VSI)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with's FREE daily email newsletter.